Found: 10
Select item for more details and to access through your institution.
Development of new immunotherapy treatments in different cancer types.
- Published in:
- Journal of Medicine & Life, 2016, v. 9, n. 3, p. 240
- By:
- Publication type:
- Article
Metastatic clear cell renal carcinoma - an unusual response to Temsirolimus in second line therapy.
- Published in:
- Journal of Medicine & Life, 2016, v. 9, n. 2, p. 193
- By:
- Publication type:
- Article
Monitoring the production of reactive oxygen species in experimental melanoma.
- Published in:
- Journal of Medicine & Life, 2013, v. 6, n. 3, p. 235
- By:
- Publication type:
- Article
Intratumoral heterogeneity in breast cancer – a real challenge for diagnosis and treatment.
- Published in:
- Oncolog-Hematolog, 2022, n. 58, p. 42
- By:
- Publication type:
- Article
Clear cell renal carcinoma - evolution of metastatic disease and overall survival after four lines of targeted therapy. Case report.
- Published in:
- Oncolog-Hematolog, 2017, n. 41, p. 32, doi. 10.26416/onhe.41.4.2017.1349
- By:
- Publication type:
- Article
The importance of genetic testing in cancer.
- Published in:
- Oncolog-Hematolog, 2017, n. 41, p. 16, doi. 10.26416/onhe.41.4.2017.1347
- By:
- Publication type:
- Article
Ocular melanoma - from theory to medical practice.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Immunotherapy and mTOR inhibitors a new perspective in the treatment of advanced and metastatic urothelial carcinomas.
- Published in:
- Oncolog-Hematolog, 2017, n. 39, p. 33
- By:
- Publication type:
- Article
Treatment of metastatic renal cell carcinoma with TKI and mTOR therapy: a case report.
- Published in:
- Oncolog-Hematolog, 2015, n. 30, p. 42
- By:
- Publication type:
- Article
Characterizarea melanomului malign experimental indus din linii celulare transformate genetic.
- Published in:
- Oncolog-Hematolog, 2014, n. 27, p. 26
- By:
- Publication type:
- Article